Trump Team Weighs Pulling Funding for Moderna Bird Flu Vaccine
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.
Related Articles
Reeling from Trump contract cuts, the National Academies prepares for ‘a fairly radical downsizing’
Nation’s leading advisory body on issues of science and technology is “preparing for a fairly radical downsizing.”
Reeling from Trump contract cuts, the National Academies prepares for ‘a fairly radical downsizing’
Nation’s leading advisory body on issues of science and technology is “preparing for a fairly radical downsizing.”
The best from STAT Breakthrough West!
Last week STAT held our Breakthrough West Summit, an all-day event focused on hopes for artificial intelligence in medicine and fears for the scientific infrastructure…
News Editor
STAT is looking for a full-time, versatile editor who will be key to our operation in the afternoons and evenings.
I’m a Republican former congressman and doctor. The new HHS placebo-controlled trial mandate is dangerous
“The notion that we should require placebo trials even when there’s already a safe, effective vaccine goes against decades of established norms in clinical research,”…
FDA advisory panel split on whether agency should require updates of Covid-19 vaccine
Some members of the Vaccines and Related Biologics Products Advisory Committee worried that a strain change would require new testing that could delay delivery of…
The FDA is circumventing key roles and procedures for licensure and use of Covid vaccines
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes.
FDA advisory panel split on whether agency should require updates of Covid-19 vaccine
Some members of the Vaccines and Related Biologics Products Advisory Committee worried that a strain change would require new testing that could delay delivery of…
Merus drug, with immunotherapy, shows preliminary survival boost for patients with head and neck cancer
A Merus drug, combined with Keytruda, shows preliminary survival gains in newly diagnosed metastatic head and neck cancer
The FDA is circumventing key roles and procedures for licensure and use of Covid vaccines
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes.